Suppr超能文献

聚己内酯共乳酸(PCLA)支架中神经营养因子-3的控释对大鼠脊髓损伤模型中移植神经干细胞存活及神经元分化的影响

The effects of controlled release of neurotrophin-3 from PCLA scaffolds on the survival and neuronal differentiation of transplanted neural stem cells in a rat spinal cord injury model.

作者信息

Tang Shuo, Liao Xiang, Shi Bo, Qu Yanzhen, Huang Zeyu, Lin Qiang, Guo Xiaodong, Pei Fuxing

机构信息

Department of Orthopaedics, West China Hospital, Sichuan University, Chengdu, China.

Department of Pain Medicine, Shenzhen Nanshan Hospital, Shenzhen, China.

出版信息

PLoS One. 2014 Sep 12;9(9):e107517. doi: 10.1371/journal.pone.0107517. eCollection 2014.

Abstract

Neural stem cells (NSCs) have emerged as a potential source for cell replacement therapy following spinal cord injury (SCI). However, poor survival and low neuronal differentiation remain major obstacles to the use of NSCs. Biomaterials with neurotrophic factors are promising strategies for promoting the proliferation and differentiation of NSCs. Silk fibroin (SF) matrices were demonstrated to successfully deliver growth factors and preserve their potency. In this study, by incorporating NT-3 into a SF coating, we successfully developed NT-3-immobilized scaffolds (membranes and conduits). Sustained release of bioactive NT-3 from the conduits for up to 8 weeks was achieved. Cell viability was confirmed using live/dead staining after 14 days in culture. The efficacy of the immobilized NT-3 was confirmed by assessing NSC neuronal differentiation in vitro. NSC neuronal differentiation was 55.2 ± 4.1% on the NT-3-immobilized membranes, which was significantly higher than that on the NT-3 free membrane. Furthermore, 8 weeks after the NSCs were seeded into conduits and implanted in rats with a transected SCI, the conduit+NT-3+NSCs group achieved higher NSC survival (75.8 ± 15.1%) and neuronal differentiation (21.5 ± 5.2%) compared with the conduit+NSCs group. The animals that received the conduit+NT-3+NSCs treatment also showed improved functional outcomes, as well as increased axonal regeneration. These results indicate the feasibility of fabricating NT-3-immobilized scaffolds using the adsorption of NT-3/SF coating method, as well as the potential of these scaffolds to induce SCI repair by promoting survival and neuronal differentiation of transplanted NSCs.

摘要

神经干细胞(NSCs)已成为脊髓损伤(SCI)后细胞替代治疗的潜在细胞来源。然而,低存活率和低神经元分化率仍然是使用神经干细胞的主要障碍。含有神经营养因子的生物材料是促进神经干细胞增殖和分化的有前景的策略。丝素蛋白(SF)基质已被证明能成功递送生长因子并保持其活性。在本研究中,通过将神经营养因子-3(NT-3)掺入丝素蛋白涂层中,我们成功开发了固定有NT-3的支架(膜和导管)。实现了生物活性NT-3从导管中持续释放长达8周。培养14天后,使用活/死染色法确认细胞活力。通过评估神经干细胞在体外的神经元分化来确认固定化NT-3的功效。在固定有NT-3的膜上,神经干细胞的神经元分化率为55.2±4.1%,显著高于无NT-3的膜。此外,将神经干细胞接种到导管中并植入SCI横断大鼠体内8周后,与导管+神经干细胞组相比,导管+NT-3+神经干细胞组实现了更高的神经干细胞存活率(75.8±15.1%)和神经元分化率(21.5±5.2%)。接受导管+NT-3+神经干细胞治疗的动物还表现出功能结果改善以及轴突再生增加。这些结果表明使用NT-3/丝素蛋白涂层吸附法制备固定有NT-3的支架的可行性,以及这些支架通过促进移植神经干细胞的存活和神经元分化来诱导SCI修复的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c390/4162607/7f617b2bea85/pone.0107517.g001.jpg

相似文献

2
Transplantation of tissue engineering neural network and formation of neuronal relay into the transected rat spinal cord.
Biomaterials. 2016 Dec;109:40-54. doi: 10.1016/j.biomaterials.2016.08.005. Epub 2016 Aug 4.
5
Cograft of neural stem cells and schwann cells overexpressing TrkC and neurotrophin-3 respectively after rat spinal cord transection.
Biomaterials. 2011 Oct;32(30):7454-68. doi: 10.1016/j.biomaterials.2011.06.036. Epub 2011 Jul 23.

引用本文的文献

1
Silk fibroin carriers with sustained release capacity for treating neurological diseases.
Front Pharmacol. 2023 May 5;14:1117542. doi: 10.3389/fphar.2023.1117542. eCollection 2023.
2
3
Current Concepts of Biomaterial Scaffolds and Regenerative Therapy for Spinal Cord Injury.
Int J Mol Sci. 2023 Jan 28;24(3):2528. doi: 10.3390/ijms24032528.
4
Prospects for the use of olfactory mucosa cells in bioprinting for the treatment of spinal cord injuries.
World J Clin Cases. 2023 Jan 16;11(2):322-331. doi: 10.12998/wjcc.v11.i2.322.
8
Injectable, macroporous scaffolds for delivery of therapeutic genes to the injured spinal cord.
APL Bioeng. 2021 Mar 9;5(1):016104. doi: 10.1063/5.0035291. eCollection 2021 Mar.
9
Stem Cell Therapy for Spinal Cord Injury.
Cell Transplant. 2021 Jan-Dec;30:963689721989266. doi: 10.1177/0963689721989266.
10
Therapeutic Plasticity of Neural Stem Cells.
Front Neurol. 2020 Mar 20;11:148. doi: 10.3389/fneur.2020.00148. eCollection 2020.

本文引用的文献

1
In situ forming acyl-capped PCLA-PEG-PCLA triblock copolymer based hydrogels.
Biomaterials. 2013 Oct;34(32):8002-11. doi: 10.1016/j.biomaterials.2013.07.046. Epub 2013 Jul 23.
3
Immobilization of heparan sulfate on electrospun meshes to support embryonic stem cell culture and differentiation.
J Biol Chem. 2013 Feb 22;288(8):5530-8. doi: 10.1074/jbc.M112.423012. Epub 2012 Dec 12.
4
Polymeric nanoparticles to control the differentiation of neural stem cells in the subventricular zone of the brain.
ACS Nano. 2012 Dec 21;6(12):10463-74. doi: 10.1021/nn304541h. Epub 2012 Nov 29.
5
BDNF: the career of a multifaceted neurotrophin in spinal cord injury.
Exp Neurol. 2012 Dec;238(2):254-64. doi: 10.1016/j.expneurol.2012.09.001. Epub 2012 Sep 12.
6
Long-distance growth and connectivity of neural stem cells after severe spinal cord injury.
Cell. 2012 Sep 14;150(6):1264-73. doi: 10.1016/j.cell.2012.08.020.
7
Bone induction through controlled release of novel BMP-2-related peptide from PTMC₁₁-F127-PTMC₁₁ hydrogels.
Biomed Mater. 2012 Feb;7(1):015008. doi: 10.1088/1748-6041/7/1/015008. Epub 2012 Jan 27.
8
The effect of long-term release of Shh from implanted biodegradable microspheres on recovery from spinal cord injury in mice.
Biomaterials. 2012 Apr;33(10):2892-901. doi: 10.1016/j.biomaterials.2011.12.048. Epub 2012 Jan 13.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验